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There  is  no  gold  standard  for  detection  of Rotavirus  Group  A  (RVA),  one  of the  main  causes  of  diarrhea
in  neonatal  animals.  Sensitive  and  speciﬁc  real-time  RT-PCR  (rtRT-PCR)  assays  are  available  for  RVA  but
require  submission  of the clinical  samples  to  diagnostic  laboratories.  Patient-side  immunoassays  for  RVA
protein detection  have  shown  variable  results,  particularly  with  samples  from  unintended  species.  A
sensitive  and speciﬁc  test  for detection  of RVA  on the  farm  would  facilitate  rapid  management  decisions.
The  insulated  isothermal  RT-PCR  (RT-iiPCR)  assay  works  in  a portable  machine  to  allow sensitive  and
speciﬁc  on-site  testing.  The  aim  of this  investigation  was  to evaluate  a commercially  available  RT-iiPCR
assay  for RVA detection  in feces  from  different  animal  species.  This  assay  was  compared  to  an  in-house
rtRT-PCR  assay  and  a commercially  available  rtRT-PCR  kit, as  well  as  an ELISA  and  EM  for RVA  detection.
All  three  PCR  assays  targeted  the  well-conserved  NSP5  gene.  Clinical  fecal  samples  from  108  diarrheic
animals  (mainly  cattle  and  horses)  were  tested.  The  percentage  of positive  samples  by  ELISA,  EM, in-
house  rtRT-PCR,  commercial  rtRT-PCR,  and  RT-iiPCR  was  29.4%,  31%,  36.7%,  51.4%, 56.9%,  respectively.
The  agreement  between  different  assays  was high  (81.3–100%)  in samples  containing  high viral  loads.
The  sensitivity  of  the  RT-iiPCR  assay  appeared  to be  higher  than  the  commercially  available  rtRT-PCR
assay,  with  a limit of  detection  (95%  conﬁdence  index)  of 3–4 copies  of  in  vitro  transcribed  dsRNA.  In
conclusion,  the  user-friendly,  ﬁeld-deployable  RT-iiPCR  system  holds  substantial  promise  for  on-site
detection  of  RVA.
©  2016  The  Authors.  Published  by  Elsevier  B.V.  This  is  an open  access  article  under  the  CC  BY  license. Introduction
Rotavirus is classiﬁed as a member of family Reoviridae,  genus
otavirus. It is non-enveloped, 60–80 nm in diameter, and the
enome length is approximately 18.5 Kb. The genome is composed
f 11 segments of double-stranded RNA and encodes six structural
roteins (VP1–4, 6 and 7) and six non-structural proteins (NSP1-
) (Desselberger, 2014; Zhou et al., 2015). The virus capsid displays
cosahedral symmetry and contains three layers, including an outer
∗ Corresponding author at: Veterinary Diagnostic and Investigational Laboratory,
ollege of Veterinary Medicine, University of Georgia, 43 Brighton Road, Tifton, GA,
SA.
E-mail address: beckpen@uga.edu (R.P. Wilkes).
ttp://dx.doi.org/10.1016/j.jviromet.2016.05.006
166-0934/© 2016 The Authors. Published by Elsevier B.V. This is an open access article u(http://creativecommons.org/licenses/by/4.0/).
layer composed of the VP7 protein, with VP4 protein spikes, an
inner or middle VP6 glycoprotein layer, and the core shell formed
by VP2 (Desselberger, 2014).
Antigenic epitope analysis of the VP6 glycoprotein classiﬁes
the genus Rotavirus into 8 groups (A–H) (Chandler-Bostock et al.,
2015; Matthijnssens et al., 2012). Rotaviruses are characterized
by relatively high antigenic and genetic diversity, as a result of
accumulation of point mutations (genetic drift), and/or reassort-
ment of genomic segments (genetic shift) (Matthijnssens et al.,
2012). Although host species barriers and host range restriction
exist in rotavirus, reassortment can result in interspecies trans-
mission, which also contributes to the diversity and evolution of
rotavirus (Martella et al., 2010; Zhou et al., 2015).
RVA is one of the main causative agents of diarrhea in young
humans and animals (Cho et al., 2013; Zhou et al., 2015). It is ubiq-
nder the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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(CV). The assay speciﬁcity was evaluated by testing DNA and RNA
of different pathogens that are known to cause diarrhea in vari-
ous animal species, including Neorickettsia risticii (Potomac horse00 M.A. Soltan et al. / Journal of Vir
itous in the environment and relatively resistance to disinfectants.
he adult animals are the main source of infection for newborn
nimals, and serological surveys revealed that 50–100% of adult
nimals have an immune response against RVA (Schlafer and Scott,
979). Clinically healthy newborn animals may  also shed RVA, but
he prevalence is lower compared to animals exhibiting diarrhea
Kaminjolo and Adesiyun, 1994). Studies have shown that detec-
ion of rotavirus in the presence of diarrhea is a signiﬁcant ﬁnding
n calf diarrhea (Cho et al., 2013). Additionally, rotavirus has been
hown to be signiﬁcantly associated with liquid diarrhea in 9- to
1-day-old dairy calves (Al Mawly et al., 2015) and also in beef
alves (Cho et al., 2013).
There are many assays used for diagnosis of RVA. Historically,
iagnostic laboratories routinely used electron microscopy (EM) for
etection of the virus. However, due to the costs of the microscope
nd its maintenance, as well as the required technical expertise, this
ethod has lost favor. Additionally, EM lacks sensitivity, requir-
ng ∼106 viral particles/ml for virus detection (Maes et al., 2003).
mmunoassays (such as ELISAs) have replaced EM as the diagnostic
est of choice for detection of viral antigen because of their ease of
se and speed of obtaining a result (Desselberger, 2014). Most of the
ommercially available ELISA kits are based on monoclonal anti-
odies against VP6 glycoprotein, which is expressed at a high level
uring infection. The VP6 glycoprotein is conserved among RVA of
ifferent animal species, allowing cross-reactivity and detection of
he virus from different hosts. Therefore, the commercially avail-
ble human RVA ELISA assays have been used for detection of RVA in
nimals (Bailey et al., 2013). However, as a result of antigenic drift,
here are several variants or genotypes of RVA VP6 that have been
escribed (Mino et al., 2015). Differences among these VP6 geno-
ypes inﬂuence the performance of various commercially available
P6 based immunoassays. Therefore, diagnostic kit validation for
ach species is necessary. Not all the assays have been validated
or use in all animal species, and this is particularly true for horses
Mino et al., 2015). In fact, one human RVA rapid immunoassay
eveloped for patient-side use was shown not to work in detection
f RVA in horses (Slovis et al., 2014).
Recently, molecular techniques such as RT-PCR and real-time
tRT-PCR have replaced other diagnostic tests with the advantage
f higher analytical sensitivity and speciﬁcity (Slovis et al., 2014).
owever, these types of assays are run in commercial or diagnos-
ic laboratories and require expensive equipment and advanced
echnical skills, resulting in increasing costs to the producer, which
eads to a reduction in the use of laboratory assays to support ﬁeld
isease investigations (Izzo et al., 2012). Therefore, the aim of our
nvestigation was to evaluate a recently available insulated isother-
al  RT-PCR (RT-iiPCR) reagent set (POCKITTM Rotavirus A Reagent
et, GeneReach USA, Lexington, MA,  USA) with use of a portable PCR
achine, which could potentially be used for point-of-need detec-
ion for RVA in the feces of different animal species. The assay was
ompared to an in-house rtRT-PCR assay, a commercially available
tRT-PCR kit, a commercially available ELISA, and EM.
. Materials and methods
.1. Clinical specimens
A total of 108 fecal samples from clinically affected animals,
ubmitted to the University of Tennessee, College of Veterinary
edicine, Clinical Virology Laboratory, were used for comparison
etween different diagnostic assays. Nucleic acids were extracted
ith an automated nucleic acid extraction system according to the
anufacturer’s instructions (tacoTM mini, GeneReach USA) from all
08 samples for molecular testing (in-house real-time RT-PCR, the
ommercially available real-time RT-PCR, and the RT-iiPCR reagental Methods 235 (2016) 99–104
set). Brieﬂy, 200 mg  of fecal sample was  added to 1 ml  PBS and
200 l of the supernatant was  used for extraction. Nucleic acids
were tested immediately following extraction or were stored at
−80 ◦C until tested.
2.2. Electron microscopy
Approximately ﬁve grams of fecal material were suspended in
10 ml  distilled water and centrifuged at 14,000g for 50 min. The
fecal pellet was re-suspended in 2 ml  of distilled water and 100 l of
the suspension was mixed with 100 l of 3% phosphotungstic acid
(pH 7.4) in 1 ml  of distilled water. The mixture was  then nebulized
onto a Carbon Type-B, 200-mesh copper grid (TED Pella, Redding,
CA, USA). The grids were examined by an electron microscope (Zeiss
Auriga, University of Tennessee, Advanced Microscopy and Imaging
Center, Knoxville, TN, USA). Eighty four of the fecal samples were
available for testing by EM.
2.3. ELISA
A commercially available sandwich ELISA, targeting the VP6 of
human RVA (PremierTM Rotaclone ELISA kit, Meridian Bioscience,
Cincinnati, OH, USA), was  used for testing the fecal samples, accord-
ing to the manufacturer’s instructions. Eighty-ﬁve of the fecal
samples were available for testing by ELISA.
2.4. In-house rtRT-PCR assay
The published nucleotide sequences of RVA non-structural pro-
tein 5 (NSP5), from different animal species (62 bovine, 12 equine,
4 caprine, 1 ovine and 3 canine), were retrieved from GenBank1
and aligned using MAFFT software.2 Primers and a probe were
designed, using the GenScript online software,3 to amplify an area
of 141 bp. Primer and probe sequences are shown in Table 1. One-
step real-time RT-PCR assay was performed using the SuperScript®
III Platinum® One-Step qRT-PCR Kit (Invitrogen, Thermo Fisher
Scientiﬁc, Carlsbad, CA, USA) in a StepOneTM real-time PCR sys-
tem (Applied Biosystems, Thermo Fisher Scientiﬁc, Foster City, CA,
USA). The proper concentrations of primers, probe and magnesium
were optimized. The test was  performed in 25-l total reaction vol-
ume  containing 5 l of the extracted nucleic acid, 400 nM of each
primer, 200 nM of probe, 3 mM magnesium and 500 nM ROX refer-
ence dye. Following optimization, the cycle parameters were: 50 ◦C
for 30 min, 95 ◦C for 2 min, followed by 45 cycles at 95 ◦C for 15 s
and 60 ◦C for 1 min. The assay sensitivity was determined and opti-
mized by using standard RNA, which was produced by cloning the
PCR product from a positive clinical sample with the TA Cloning®
Kit with pCRTM2.1 Vector and One Shot® INVF’ Chemically Com-
petent Escherichia coli (Invitrogen, Thermo Fisher Scientiﬁc, USA)
according to manufacturer’s instructions. The puriﬁed plasmids
were sequenced to conﬁrm correct orientation, linearized, and used
as a template for synthesis of in vitro transcribed RNA using the
MEGAscript T7 Transcription Kit (Invitrogen, Thermo Fisher Sci-
entiﬁc, USA), according to manufacturer’s instructions. RNA copy
numbers were calculated and a standard curve was generated
from ten-fold serial dilutions of the RNA standard at a range from
1 × 10−1 to 1 × 10−6. The reproducibility of the assay was evalu-
ated by calculation of intra- and inter-assay coefﬁcient of variation1 http://www.ncbi.nlm.nih.gov/genbank/.
2 http://mafft.cbrc.jp/alignment/software/.
3 https://www.genscript.com/ssl-bin/app/primer.
M.A. Soltan et al. / Journal of Virological Methods 235 (2016) 99–104 101
Table  1
Primer/probe sequences for in-house real-time RT-PCR assay.
Primer/Probe Sequence Positiona
RotaReal-F 5′ TTCTGCTTCAAACGAYCCACTC 3′ 21–234
RotaReal-R 5′ GAGAAATCYACTTGRTCGCA 3′ 353–334
CRTTTGTC- BHQ 3′ 296–267
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aRotaReal-Probe 5′ FAM- TCCATAGAYACRCCAGYRTCTG
a According to GenBank accession number GU937876.
ever), Rhodococcus equi, Clostridium difﬁcile, E. coli,  Salmonella
nterica Typhimurium and Dublin, Crytosporidium parvum, bovine
iral diarrhea virus genotypes I and II, and bovine coronavirus.
.5. RT-iiPCR assay
The RT-iiPCR test (POCKITTM Rotavirus A Reagent Set) targets
he NSP5 gene. All the components of the RT-iiPCR reaction were
yophilized in one tube. The lyophilized Premix was rehydrated
efore reaction in 50 l Premix Buffer B and 5 l of sample RNA
ere added to the mixture. The mixture was transferred to an R-
ube, centrifuged and tested by the POCKITTM nucleic acid analyzer
GeneReach USA) as previously described (Wilkes et al., 2014).
he assay speciﬁcity was evaluated as described for the in-house
tRT-PCR assay. Double-stranded rotavirus NS5 RNA was synthe-
ized and used to determine sensitivity of the RT-iiPCR reagent set.
rieﬂy, a plasmid containing a partial sequence of the NSP5 gene of
he RVA/horse-wt/ZAF/EqRV-SA1/2006/G14P[12] strain (GenBank
ccession JQ345499) and the bovine rotavirus strain KJ44 strain
GenBank accession DQ494399) were used to generate positive and
egative strand RNA by in vitro transcription using the MAXIscript®
7 kit and MEGAscript® SP6 Kit (Life Technologies, Darmstadt,
ermany), respectively. Residual DNA was removed using the
mbion® Turbo DNA-freeTM kit (Life Technologies). The two  RNA
roducts were annealed to form double-stranded RNA. Resid-
al single strand RNA was removed by RNase A treatment. After
henol-chloroform extraction, integrity of the double-stranded
NA preparation was conﬁrmed by polyacrylamide gel elec-
rophoresis analysis. Concentration of RNA was determined in
 NanoDrop 1000 Spectrophotometer (NanoDrop Technologies,
ouston, TX, USA). Serial dilutions of double-stranded RNA were
ade in 40 ng/l yeast tRNA. Single use aliquots were stored
t −80 ◦C. Additionally, the sensitivity of the rotavirus RT-iiPCR
eagent set was evaluated by comparison with the commercially
vailable rtRT-PCR assay using 10-fold serial dilutions of nucleic
cid extracted from a positive bovine clinical sample.
.6. Commercially available rtRT-PCR assay
The nucleic acid samples were tested by the LSI VetMAXTM
riplex Ruminant Rotavirus & Coronavirus Real-Time PCR Kit
Thermo Fisher Scientiﬁc, USA), according to manufacturer’s
nstructions.
.7. Statistical analysis
The percentage of agreement between the different diagnostic
ssays and Cohen’s Kappa coefﬁcient were calculated using SPSS
tatistics software.4
. ResultsThe standard curve for the in-house rtRT-PCR assay gener-
ted from serially diluted standard RNA was linear (slope = −3.757)
4 http://www-01.ibm.com/software/analytics/spss/products/statistics/.Fig. 1. Standard curve for in-house real-time RT-PCR assay for rotavirus group A.
The  assay was linear over 6 orders of magnitude and was able to detect as few as 70
genomic equivalents per reaction.
(Fig. 1) and the coefﬁcient of linear regression (R2) was 0.998. The
assay efﬁciency was  estimated to be 84.6%. The developed assay
was sensitive and able to detect 70 genomic equivalents of the
target NSP5 gene per reaction. Furthermore, it was speciﬁc, with
no ampliﬁcation detected from DNA or RNA from other pathogens
known to cause diarrhea in animal species. The assay was repro-
ducible with intra- and inter-assay CVs ranging from 0.009 to 0.022
and 0.004 to 0.033, respectively.
The limit of detection (95% conﬁdence interval) for the RT-iiPCR
reagent set was  4 and 3 copies of dsRNA, based on using log dilu-
tions of in vitro transcribed dsRNA containing target bovine and
equine rotavirus sequences, respectively. The comparison between
sensitivity of the RT-iiPCR assay and commercially available rtRT-
PCR assay using 10-fold serial dilutions of nucleic acid from a
positive sample showed that the RT-iiPCR reagent set had a 100-
fold increase in sensitivity. Like the in-house assay, this assay was
also speciﬁc, with no ampliﬁcation in any of the samples used for
speciﬁcity testing.
There was variation in the percentage of positive samples
detected by each assay. The RT-iiPCR assay detected the most, while
EM detected the least. The overall percentages of positive sam-
ples by each diagnostic assay are shown in Table 2. There was a
signiﬁcant difference in the number of positive samples detected
with the in-house rtRT-PCR assay versus the other two  molecu-
lar tests. These differences are evident when comparing the Kappa
coefﬁcients (Table 3).
The EM assay results showed substantial agreement in compar-
ison to ELISA results. This agreement becomes fair when compared
to the RT-iiPCR reagent set and the commercial rtRT-PCR kit,
and moderate in comparison to the in-house rtRT-PCR assay. The
ELISA showed moderate agreement with the RT-iiPCR reagent set
and commercial rtRT-PCR assay but had substantial agreement
with the in-house rtRT-PCR assay. A perfect agreement was found
between the RT-iiPCR reagent set and the commercial rtRT-PCR
assay (Table 3). Comparison between the different assays showed a
strong correlation for samples containing high viral loads (Ct values
≤25) (Table 4).
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Table 2
Percentage of positive samples by different diagnostics assays.
Animal species Assays
EM ELISAa Commercial RT-iiPCR Commercial real-time rtRT-PCR kitb In-house rtRT-PCR assay
Bovine 21/68 (30.9%) 20/54 (37%) 54/76 (71%) 52/76 (68.4%) 35/76 (46%)
Equine  1/6 (16.7%) 2/21 (9.5%) 3/22 (13.6%) 2/22 (9.1%) 2/22 (9.1%)
Caprine 1/4 (25%) 0/4 (0%) 1/4 (25%) 0/4 (0%) 0/4 (0%)
Canine  3/6 (50%) 3/6 (50%) 4/6 (66.7%) 3/6 (50%) 3/6 (50%)
Total  26/84 (31%) 25/85 (29.4%) 62/108 (57.4%) 57/108 (52.8%) 40/108 (37%)
a PremierTM Rotaclone ELISA kit, Meridian Bioscience, USA.
b LSI VetMAXTM triple ruminant Rotavirus and Coronavirus Real-Time PCR kit, Thermo Fisher Scientiﬁc, USA.
Table 3
Comparison of reliability of different diagnostic tests in detection of Rotavirus group A.
Tests in comparison Test by test agreement Agreementc
Percentage of agreement Kappa
EM vs ELISAa 85.5% 0.68 Substantial
EM  vs commercial RT-iiPCR assay 64.3% 0.37 Fair
EM  vs commercial real-time rtRT-PCR kitb 67.5% 0.40 Fair
EM  vs in-house rtRT-PCR assay 78.6% 0.56 Moderate
ELISA vs commercial RT-iiPCR assay 74.1% 0.46 Moderate
ELISA vs commercial rtRT-PCR kit 81.2% 0.59 Moderate
ELISA vs in-house rtRT-PCR assay 89.4% 0.74 Substantial
Commercial RT-iiPCR vs commercial rtRT-PCR kit 91.7% 0.84 Almost Perfect
Commercial RT-iiPCR vs in-house rtRT-PCR assay 79.6% 0.62 Substantial
Commercial rtRT-PCR kit vs in-house rtRT-PCR assay 84.3% 0.68 Substantial
a PremierTM Rotaclone ELISA kit, Meridian Bioscience, USA.
b LSI VetMAXTM triple ruminant Rotavirus and Coronavirus Real-Time PCR kit, Thermo
c Viera and Garrett, 2005.
Table 4
Percentage agreement between positive samples by Commercial Real-time rtRT-PCR
kita versus other assays, broken down by rtRT-PCR Ct values.
Ct Range Assays
EM ELISAb Commercial RT-iiPCR In-house rtRT-PCR assay
5–15 100% 100% 100% 100%
16–25 81.3% 100% 100% 94%
26–35 12% 40% 100% 83.3%
36–45 0% 22.2% 87% 9%
a LSI VetMAXTM triple ruminant Rotavirus and Coronavirus Real-Time PCR kit,
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b PremierTM Rotaclone ELISA kit, Meridian Bioscience, USA.
. Discussion
RVA is one of the most prevalent causative agents of diar-
hea in farm animals (Athanassious et al., 1994; Izzo et al., 2011;
lovis et al., 2014). It causes signiﬁcant economic losses as a result
f decreased weight gain, treatment costs, and high mortalities.
herefore, development of a highly sensitive and speciﬁc test for
oint-of-need diagnosis would be beneﬁcial to the veterinary prac-
itioner and producer because delays associated with shipping
amples to a diagnostic laboratory could be avoided, aiding in rapid
ontrol and prevention decisions (Izzo et al., 2012).
There are many commercially available lateral ﬂow
mmunochromatography assays (LAT) that can be used for
n-site detection of RVA. One brand of LAT showed favorable
esults in comparison to virus isolation and ELISA (Maes et al.,
003). However, when compared to qRT-PCR, the results have been
ariable. The limitation of antibody-based tests for the detection
f enteric pathogens is the requirement of high concentration of
ree antigen to generate a positive reaction, the free antigen is
ecreased signiﬁcantly during the course of disease. Therefore,
hese tests have lower sensitivity and could miss positive samples
ollected late in the course of clinical disease, when compared to
T-PCR (Izzo et al., 2012; Maes et al., 2003). Depending on the test Fisher Scientiﬁc, USA.
used and species tested, these tests can also have low speciﬁcity
(Izzo et al., 2012) or may  not work at all (Slovis et al., 2014).
Commercial ELISA assays and other immunoassays, while easy
to use and rapid for detection, are mostly designed for human
use and care must be taken when applying these tests for ani-
mal  use. The ELISA used in this study was able to detect RVA
from three different animal species. The agreement between EM
and ELISA was  85.5%, which was  similar to previously published
reports (Athanassious et al., 1994; Benﬁeld et al., 1984; Reynolds
et al., 1984), and both of these methods lacked the sensitivity
achieved with molecular assays, which has also been previously
reported (Izzo et al., 2012). Interestingly, three positive samples
by ELISA in this study were negative by EM and all three molec-
ular assays. The ELISA assay absorbance values for these samples
ranged from 0.2 to 0.5, which indicates low viral load according
to the manufacturer. These samples were considered false posi-
tives. False positive results are not uncommon for ELISA assays as
a result of the complex sample matrix (i.e. gut microbiota), which
can increase the probability of cross-reactions. The type of anti-
bodies (polyclonal versus monoclonal) used strongly affects their
detection efﬁciency. The use of monoclonal antibodies is usually
associated with increased speciﬁcity of the assay, but this also
creates potential problems with regard to amino acid variability
among the rotaviruses from different species
Another complication with detection of rotavirus is the fact that
it can be detected in both healthy and diseased animals. Establish-
ing a causal relationship may  be difﬁcult without demonstration
of classic histopathological changes (Izzo et al., 2012), particularly
when using highly sensitive molecular detection methods. Consid-
ering animals shed up to 108–1012 virions/ml of feces during the
acute phase of infection (Izzo et al., 2012), positive results obtained
with less sensitive methods (EM and ELISA) are more likely tois highly correlated with disease in RVA infection (Phillips et al.,
2009).
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Related to this concept is the idea that magnitude of viral
hedding (based on Ct value) can help determine disease etiology
Phillips et al., 2009). Evidence of high viral load in samples tested
ives the clinician more conﬁdence that the virus is the cause of the
isease process (Izzo et al., 2012). A high correlation between Ct
alues ≤25 and clinical disease was found in one human study that
ompared RVA shedding in clinically healthy subjects versus those
ith diarrhea (Phillips et al., 2009). We  found a higher correlation
etween test methods when we evaluated samples with Ct values
25. However, Ct values from different protocols must be inter-
reted with care because the values may  not equate to the same
iral load per gram of feces (Phillips et al., 2009). This was  actually
een in this study when comparing between the commercial rtRT-
CR assay and the in-house rtRT-PCR assay, particularly with the
ositive equine samples. The Ct values obtained by the in-house
tRT-PCR assay were 21 and 18.3, compared to 26.18 and 36.01,
espectively, by the commercial rtRT-PCR kit. While we did not
ave additional equine samples to further examine this, these high
t values from equine samples are consistent with a previous report
Matthijnssens et al., 2015) in which the same commercial molecu-
ar assay was also used for diarrheic samples from equine. Ct values
or positive samples from that study ranged from 26.18–36.01. The
uthors attributed the high Ct values to degradation of the viral
NA in the samples or mild infection. While these are certainly
ossibilities, these results do raise questions about the sensitiv-
ty of this commercial rtRT-PCR assay in the diagnosis of equine
VA. This disparity may  potentially be attributed to mismatches in
rimer and probe binding areas. The designed primers and probe
f the in-house rtRT-PCR assay contain several degenerate bases,
n an attempt to avoid problems with base mismatches. However,
s seen with the sensitivity testing and comparison between the
ssays, the in-house molecular test was less sensitive that the other
olecular assays. Based on the ﬁndings in this study when com-
aring Ct values, it is important to note that the possibility of the
igniﬁcance of lower concentrations of RNA may  not be excluded.
t values can be affected by many factors, not just mismatches in
rimer/probe binding regions or inappropriate handling and stor-
ge of the sample, but also stage of the disease and the quality of
he sample collected (Izzo et al., 2012).
The commercial RT-iiPCR assay performed in a portable PCR
achine was shown to have higher sensitivity than the other
olecular methods tested in this study. While it is possible some of
he positive samples could have been false positives, we  believe it is
ore likely associated with the increased sensitivity seen with this
est, which was demonstrated with side-by-side testing, versus the
ommercial rtRT-PCR assay, of serial dilutions of nucleic acid from
 clinical sample. High sensitivity of RT-iiPCR assays has been con-
istently demonstrated in previous reports (Ambagala et al., 2015;
alasuriya et al., 2014; Wilkes et al., 2014). The higher sensitivity
ay  be attributed to the performance of the reaction in gradient
emperature that results from the thermal convective phenom-
na associated with this type of PCR (Krishnan et al., 2002). This
llows primers and probes to anneal to sequences with mismatches
Ambagala et al., 2015).
The commercial RT-iiPCR assay incorporates a ﬂuorescent
ydrolysis probe, which increases the speciﬁcity of the assay,
unctioning more like a real-time PCR than a conventional PCR.
owever, rather than obtaining a Ct value that requires interpre-
ation, the portable machine detects the ﬂuorescent signal before
nd after the reaction and automatically converts it into a positive
r negative result. The numerical value for these ﬂuorescent signals
an be obtained from the machine for some determination about
mount of virus present in the sample, but the sensitivity of the
ignal does not correlate as well as a threshold cycle value does for
eal-time PCR. The automated interpretation of the iiPCR machine
oes however make the method easier to use without the need foral Methods 235 (2016) 99–104 103
advanced training. The portable machine is small and light weight
and can be operated with a car battery.
5. Conclusions
The three RT-PCR assays evaluated in the study were shown
in general to have comparable performance for RVA detection in
fecal samples. The real-time PCR assays are excellent tools for diag-
nostic laboratories, and the RT-iiPCR assay working in a portable
PCR machine is highly sensitive and speciﬁc and shows promise for
on-farm molecular detection of RVA.
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